Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
8847
BCR-ABL GENE p190 t(9;22) QUANTIFICATION, BONE MARROW
Method:
Real Time RT-PCR.
Mounting:
Delivery period:6
Sample:
3 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
14660
BERYLLIUM. ORINA
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:12
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
< 0.09 umol/L * 9.012 = ug/L
Review:
09/04/2015
1971
BISMUTH, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
10 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)
Request form:
Diuresis required
Sample extraction:
Use metal-free container.
Reference V.:
< 71.77 nmol/24h * 0.208986 = ug/24h
Review:
02/04/2008
11661
BREAST/OVARIAN HEREDITARY CANCER (RAD51C GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
6210
BARIUM, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 0.10 mg/L
Review:
27/05/2009
10105
BONE ALKALINE PHOSPHATASE, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Females 0 3 Years 41.90 - 107.00 ug/L
Females 13 16 Years 10.20 - 109.80 ug/L
Females 17 18 Years 5.90 - 20.00 ug/L
Females 4 8 Years 21.90 - 147.90 ug/L
Females 9 12 Years 38.60 - 111.20 ug/L
Males > 18 Years 6.00 - 30.00 ug/L
Males 0 3 Years 43.40 - 104.80 ug/L
Males 13 16 Years 15.50 - 134.00 ug/L
Males 17 18 Years 11.00 - 77.60 ug/L
Males 4 8 Years 29.70 - 123.00 ug/L
Males 9 12 Years 52.30 - 152.30 ug/L
Postmenopause Females > 18 Years 6.00 - 26.00 ug/L
Premenopause Females > 18 Years 3.00 - 19.00 ug/L
Review:
14/02/2011
11947
BABESIA DNA SPP. , BLOOD
Method:
Polymerase chain reaction.
Mounting:
Delivery period:21
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Is not detected
Review:
02/05/2014
15793
BRANCHIOOTORENAL SYNDROME (EYA1 GENE), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
1
BLOOD COUNT
Method:
Cytometry/Cytochemical.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Hematíes:
Both 6 8 Years 3.80 - 4.90 10Exp12/L
Hematocrito:
Males 17 45 Years 0.39 - 0.49 L/L * 100 = %
Volumen Corpuscular Medio:
83.00 - 97.00 fL
Hematíes:
Both 3 5 Years 3.70 - 4.90 10Exp12/L
Females 45 64 Years 3.80 - 5.30 10Exp12/L
Hemoglobina:
Males 65 74 Years 126.00 - 174.00 g/L * 0.1 = g/dL
Leucocitos:
Both 1 2 Years 6.00 - 17.00 10Exp9/L
Linfocitos:
17.00 - 45.00 %
Neutrófilos Segmentados:
55.00 - 70.00 %
Hematíes:
Both 1 2 Years 3.80 - 4.80 10Exp12/L
Hematocrito:
Females 17 45 Years 0.35 - 0.45 L/L * 100 = %
Females 64 74 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Females 18 44 Years 117.00 - 155.00 g/L * 0.1 = g/dL
Females 45 64 Years 117.00 - 160.00 g/L * 0.1 = g/dL
Males 12 14 Years 120.00 - 160.00 g/L * 0.1 = g/dL
Males 15 17 Years 117.00 - 166.00 g/L * 0.1 = g/dL
Leucocitos:
Both 0 6 Months 6.00 - 17.50 10Exp9/L
Eosinófilos:
1.00 - 6.00 %
Hematíes:
Males 12 14 Years 4.10 - 5.20 10Exp12/L
Hematocrito:
Males 45 64 Years 0.39 - 0.50 L/L * 100 = %
Males 64 74 Years 0.37 - 0.51 L/L * 100 = %
Neutrófilos Cayados:
0.20 - 4.00 %
Hematocrito:
Females 45 64 Years 0.35 - 0.47 L/L * 100 = %
Hemoglobina:
Females 15 17 Years 117.00 - 153.00 g/L * 0.1 = g/dL
I.Distribucion Plaquetas:
8.00 - 65.00 %
Leucocitos:
Both 4 5 Years 5.50 - 15.50 10Exp9/L
Both 5 6 Years 5.00 - 14.50 10Exp9/L
C.Hb.Corpuscular Media:
320.00 - 360.00 g/L * 0.1 = g/dL
Hb.Corpuscular Media:
27.00 - 31.00 pg
Hematíes:
Females 18 44 Years 4.20 - 5.40 10Exp12/L
Hematocrito:
Both 6 8 Years 0.33 - 0.41 L/L * 100 = %
Females 12 14 Years 0.34 - 0.44 L/L * 100 = %
Males 12 14 Years 0.35 - 0.45 L/L * 100 = %
Hemoglobina:
Both 3 4 Months 10.30 - 14.10 g/L * 0.1 = g/dL
Both 5 9 Years 11.50 - 14.50 g/L * 0.1 = g/dL
Females 12 14 Years 115.00 - 150.00 g/L * 0.1 = g/dL
Hematíes:
Both 0 12 Months 4.10 - 5.30 10Exp12/L
Males 15 17 Years 4.20 - 5.60 10Exp12/L
Hematocrito:
Both 0 1 Years 0.33 - 0.41 L/L * 100 = %
Hemoglobina:
Both 0 1 Months 10.70 - 17.10 g/L * 0.1 = g/dL
Both 1 2 Months 9.40 - 13.00 g/L * 0.1 = g/dL
Both 1 5 Years 11.00 - 14.00 g/L * 0.1 = g/dL
Males 45 64 Years 131.00 - 172.00 g/L * 0.1 = g/dL
Leucocitos:
Both 9 16 Years 4.50 - 13.50 10Exp9/L
Linfocitos:
1300.00 - 4000.00 cel/mm³
Hematíes:
Both 9 11 Years 3.90 - 5.10 10Exp12/L
Females 15 17 Years 3.90 - 5.10 10Exp12/L
Males 45 64 Years 4.20 - 5.60 10Exp12/L
Hematocrito:
Both 3 5 Years 0.32 - 0.42 L/L * 100 = %
Females 14 17 Years 0.34 - 0.44 L/L * 100 = %
Hemoglobina:
Females 65 74 Years 117.00 - 161.00 g/L * 0.1 = g/dL
Leucocitos:
Both 7 8 Years 4.50 - 13.50 10Exp9/L
Basófilos:
0.20 - 1.20 %
Hematíes:
Females 65 74 Years 3.80 - 5.20 10Exp12/L
Hematocrito:
Both 9 11 Years 0.34 - 0.43 L/L * 100 = %
Neutrófilos Cayados:
< 500.00 cel/mm³
Plaquetas:
150.00 - 450.00 10Exp9/L
Hematíes:
Females 12 14 Years 3.80 - 5.00 10Exp12/L
Males 18 44 Years 4.70 - 6.00 10Exp12/L
Índ.Distribución Hematíes:
Males 11.00 - 15.00 %
Leucocitos:
Both 16 21 Years 4.50 - 11.00 10Exp9/L
Basófilos:
10.00 - 150.00 cel/mm³
Eosinófilos:
50.00 - 500.00 cel/mm³
Hematocrito:
Males 14 17 Years 0.37 - 0.48 L/L * 100 = %
Hemoglobina:
Both 9 12 Years 12.00 - 15.00 g/L * 0.1 = g/dL
Índ.Distribución Hematíes:
Females 10.00 - 14.00 %
Plaquetocrito:
0.00 L/L * 100 = %
Hematíes:
Males 65 74 Years 3.80 - 5.80 10Exp12/L
Hematocrito:
Both 1 2 Years 0.32 - 0.40 L/L * 100 = %
Hemoglobina:
Males 18 44 Years 132.00 - 173.00 g/L * 0.1 = g/dL
Monocitos:
150.00 - 900.00 cel/mm³
2.00 - 8.00 %
Neutrófilos Segmentados:
2500.00 - 7500.00 cel/mm³
Volumen Plaquetar Medio:
6.00 - 11.00 fL
261
BLOOD GROUP (A B O), BLOOD
Mounting:
Delivery period:2
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
22/05/2013
551
BILE ACIDS, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 10.00 umol/L * 0.408497 = ug/mL
Review:
14/05/2013
680
BETA2-MICROGLOBULIN, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
51.58 - 200.40 nmol/L * 0.011806 = mg/L
691
BETA-HYDROXYBUTYRATE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Both > 15 Years < 0.43 mmol/L * 104.1 = mg/L
Both 0 15 Years 0.02 - 0.29 mmol/L * 104.1 = mg/L
759
BICARBONATE, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:3
Sample:
1 mL Plasma Heparin lithium (-8 ºC - Freeze)
Alt. 1 mL Serum (-8 ºC - Freeze)
Sample extraction:
Cap tube immediately to avoid contact with air.
Reference V.:
23.00 - 29.00 mmol/L * 1.0 = mEq/L
781
BRUCELLA ANTIBODIES (ROSA DE BENGALA), SERUM
Method:
Agglutination.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
R.Values:
This technique is a screening test. If positive, it should be complemented by other serologic tests for diagnosing brucellosis.
Review:
12/01/2004
782
BRUCELLA ANTIBODIES (COOMBS), SERUM
Method:
Immunocapture-Agglutination.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Indeterminate: 1/160 1/1280 Título
Positive:
> 1/1280 Título
Negative:
< 1/160 Título
R.Values:
For an adequate assessment of the result, the use of a single serum specimen should be accompanied by a series of assessments, such as: age and epidemiologic data of the patient, as well as the prevalence of disease in the area.
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
12/01/2004
905
BETA-CAROTENE, SERUM
Method:
High efficiency liquid chromatography - Ultraviolet.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Transport:
Protect from light.
Reference V.:
0.14 - 1.58 umol/L * 53.7634 = ug/dL
Review:
20/10/2011
993
BLADDER TUMOR ANTIGEN (BTA), URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 14.00 KU/L * 1.0 = U/mL
1027
BIPERIDENE, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:17
Sample:
3 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
10.00 - 100.00 ug/L
2987
BETA-CROSS-LAPS (CTX), SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
Males > 71 Years < 0.85 ug/L
Males 0 49 Years < 0.58 ug/L
Males 50 70 Years < 0.70 ug/L
Jaw osteonecrosis in Tº with Biophosphonates:

Intermediate relative risk0.10 - 0.15 ug/L
Low relative risk:
> 0.15 ug/L
High relative risk:
< 0.10 ug/L
Postmenopause Females < 1.01 ug/L
Premenopause Females < 0.57 ug/L
Review:
09/07/2013
1267
BROMIDE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Lethal C.:
> 300.00 mmol/L / 0.125 = mg/dL
Reference V.:
< 1.87 mmol/L / 0.125 = mg/dL
Confusion > 50.00 mmol/L / 0.125 = mg/dL
1367
BORRELIA BURGDORFERI ANTIBODIES, IgG (CONFIRMATORY), SERUM
Method:
Immunoblot.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
R.Values:
This technique identifies IgG antibodies to the following antigens: p83, p41(flagellin), p39(BmpA), p31(OspA), p34(OspB), p25 (OspC), p21/22, and p18.
Reference V.:
Negative
1368
BORRELIA BURGDORFERI ANTIBODIES, IgM (CONFIRMATORY), SERUM
Method:
Immunoblot.
Mounting:
Delivery period:11
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
R.Values:
This technique identifies IgM antibodies to the following antigens: p83, p41(flagellin), p39(BmpA), p31(OspA), p34(OspB), p25 (OspC), p21/22, and p18.
Reference V.:
Negative
1413
BORDETELLA PARAPERTUSSIS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Positive: >= to 1/160 Titulo
Negative:
< 1/160 Titulo
R.Values:
There is an important cross-reaction between Bordetella pertussis and Bordetella parapertussis, so parallel titration of two sera (seroconversion) using both determinations is recommended as a way of clarifying the species involved.
Review:
22/12/2008
1414
BRUCELLA MELITENSIS DNA, BLOOD
Method:
Polymerase chain reaction.
Mounting:
Delivery period:10
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Negative
1415
BORRELIA BURGDORFERI ANTIBODIES, IgM, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 0.90 Indice
Indeterminate:
0.90 - 1.09 Indice
Positive:
> 1.09 Indice
Review:
04/12/2008
1416
BORRELIA BURGDORFERI ANTIBODIES, IgG, SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 15.00 UA/mL
Indeterminate:
10.00 - 15.00 UA/mL
Negative:
< 10.00 UA/mL
Review:
14/07/2005
1417
BRUCELLA ANTIBODIES, IgG, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.10 Indice
Negative:
< 0.90 Indice
Positive:
> 1.10 Indice
Review:
21/06/2013
1418
BRUCELLA ANTIBODIES IgM, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: > 1.10 Indice
Negative:
< 0.90 Indice
Indeterminate:
0.90 - 1.10 Indice
Review:
25/06/2013
1419
BORDETELLA PERTUSSIS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/128 Titulo
Negative:
< 1/128 Titulo
Review:
22/12/2008
1420
BORDETELLA PERTUSSIS ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/256 Titulo
Positive:
>= to 1/256 Titulo
R.Values:
There is an important cross-reaction between Bordetella pertussis and Bordetella parapertussis, so parallel titration of two sera (seroconversion) using both determinations is recommended as a way of clarifying the species involved.
Review:
22/12/2008
1612
BORDETELLA PARAPERTUSSIS ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/160 Titulo
Negative:
< 1/160 Titulo
Review:
22/12/2008
1694
BORRELIA BURGDORFERI DNA, BIOLOGICAL FLUID
Method:
Real Time PCR.
Mounting:
Delivery period:7
Sample:
0.5 mL Cerebrospinal liquid (-8 ºC - Freeze)
Alt. 5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 0.5 mL Serum (-8 ºC - Freeze)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
If sending blood, please refrigerate specimen.
Reference V.:
Negative
1740
BCR-ABL GENE p210 t(9;22) QUANTIFICATION, BLOOD
Method:
Real Time RT-PCR.
Mounting:
Delivery period:6
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
1741
BCR-ABL GENE p190 t(9;22) QUANTIFICATION, BLOOD
Method:
Real Time RT-PCR.
Mounting:
Delivery period:6
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
1744
BIOGENIC AMINES AND PTERINES DEFICIENCY, CSF
Method:
High efficiency liquid chromatography - Electrochemical.
Mounting:
Delivery period:35
Sample:
1 mL Cerebrospinal liquid (-8 ºC - Freeze)
Request form:
Clinical information required.
It´s necessary the birth date.
Transport:
Protect from light.
Reference V.:
Both 1 5 Months 217.00 - 1142.00 noml/L
Both 11 16 Years 1.44 - 3.17
Both 3 6 Years 4.00 - 23.00 nmol/L
Both 6 24 Months 8.00 - 43.00 nmol/L
Both 7 10 Years 1.20 - 3.45
Both 3 6 Years 304.00 - 658.00 nmol/L
Both 6 24 Months 170.00 - 490.00 noml/L
Both 6 24 Months 344.00 - 906.00 nmol/L
Both 1 5 Months 12.00 - 44.00 nmol/L
Both 1 5 Months 9.00 - 34.00 nmol/L
Both 3 6 Years 3.00 - 64.00 nmol/L
Both 6 24 Months 1.60 - 15.00 nmol/L
Both 7 10 Years 10.00 - 46.00 nmol/L
Both 1 5 Months 20.00 - 162.00 nmol/L
Both 1 5 Months 30.00 - 124.00 nmol/L
Both 11 16 Years 13.70 - 36.00 nmol/L
Both 11 16 Years 2.40 - 12.00 nmol/L
Both 11 16 Years 63.00 - 185.00 noml/L
Both 6 24 Months 1.11 - 3.48
Both 0 30 Days 6.00 - 24.00 nmol/L
Both 1 5 Months 354.00 - 1328.00 nmol/L
Both 3 6 Years 1.92 - 3.44
Both 3 6 Years 106.00 - 316.00 noml/L
Both 6 24 Months 20.00 - 80.00 nmol/L
Both 6 24 Months 4.00 - 50.00 nmol/L
Both 6 24 Months 8.00 - 54.00 nmol/L
Both 1 5 Months 1.16 - 2.40
Both 3 6 Years 10.00 - 52.00 nmol/L
Both 0 30 Days 12.00 - 64.00 nmol/L
Both 0 30 Days 22.00 - 70.00 nmol/L
Both 0 30 Days 24.00 - 148.00 nmol/L
Both 11 16 Years 11.00 - 46.00 nmol/L
Both 3 6 Years 22.00 - 54.00 nmol/L
Both 7 10 Years 5.00 - 60.00 nmol/L
Both 0 30 Days 44.00 - 106.00 nmol/L
Both 11 16 Years 10.00 - 24.00 nmol/L
Both 11 16 Years 156.00 - 410.00 nmol/L
Both 3 6 Years 7.00 - 55.00 nmol/L
Both 7 10 Years 202.00 - 596.00 nmol/L
Both 0 30 Days 0.76 - 1.67
Both 1 5 Months 2.70 - 26.00 nmol/L
Both 11 16 Years 3.00 - 54.00 nmol/L
Both 0 30 Days 658.00 - 1434.00 nmol/L
Both 7 10 Years 1.60 - 16.00 nmol/L
Both 7 10 Years 13.00 - 68.00 nmol/L
Both 7 10 Years 8.20 - 68.00 nmol/L
Both 7 10 Years 87.00 - 366.00 noml/L
Both 0 30 Days 428.00 - 1122.00 noml/L
1810
BARTONELLA HENSELAE ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/64 Titulo
Positive:
>= to 1/64 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
27/02/2004
1940
BARBITURATES (SCREENING), URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:2
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
200.00 ug/L
Reference V.:
Negative
Review:
09/04/2013
1941
BENZODIAZEPINES (SCREENING), URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:1
Sample:
3 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
200.00 ug/L
Reference V.:
Negative
Review:
09/04/2013
2019
BETA2-MICROGLOBULIN, URINE
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 25.41 nmol/L * 11.8064 = ug/L
Review:
09/04/2013
2047
BENZODIAZEPINES (CONFIRMATORY), URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:17
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Discriminant V.:
150.00 ug/L
Reference V.:
Negative
2134
BORRELIA BURGDORFERI ANTIBODIES, IgG, CSF
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 4.50 - 5.50 UA/mL
Positive:
> 5.50 UA/mL
Negative:
< 4.50 UA/mL
2164
BARTONELLA HENSELAE ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/20 Titulo
Positive:
>= to 1/20 Titulo
Review:
17/03/2009
2214
BRAIN NATRIURETIC PEPTIDE (BNP), PLASMA
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:6
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Interpretation:

H. F. Very likely > 500.00 ng/L * 1 = pg/mL
H. F. Unlikely < 100.00 ng/L * 1 = pg/mL
H. F. Doubtful 100.00 - 500.00 ng/L * 1 = pg/mL
Review:
09/04/2013
2225
BACLOFEN, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:7
Sample:
3 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
0.10 - 0.60 mg/L
2395
BROMIDE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
BEI:

Exposed personnel (Methylene bromide) < 250.00 umol/g crea. / 12.51 = mg/g crea.
Reference V.:

Unexposed personnel < 62.57 umol/g crea. / 12.51 = mg/g crea.
2434
BETA-THALASSEMIA (HBB GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:25
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
09/09/2013
2474
BCR-ABL GENE p210 t(9;22) QUALITATIVE, BLOOD
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 2 mL Bone marrow Tripotassium EDTA Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
Reported for each case
Review:
03/12/2013
2996
BP-180 ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
5001
BIOPSY
Method:
Microscopic observation.
Mounting:
Delivery period:7
Sample:
1 piece/s Tissue Formaldehyde buffer (10%) (12-20 ºC - Ambient Temp.)
R.Values:
Reported for each case.
Review:
05/02/2007
5010
BIOPSY
Method:
Microscopic observation.
Mounting:
Delivery period:7
Sample:
1 piece/s Tissue Formaldehyde buffer (10%) (12-20 ºC - Ambient Temp.)
R.Values:
Reported for each case.
6015
BACTERIOLOGICAL ANALISYS, DIALYSE WATER
Method:
Look method for each procedure.
Mounting:
Delivery period:7
Sample:
1000 mL Dialysis water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
6027
BASIC POTABILITY ANALYSIS, DRINKING WATER
Method:
Look method for each procedure.
Mounting:
Delivery period:7
Sample:
100 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
1000 mL Water (Recipient, sterile) ( Sodium Thiosulfate )
Sample extraction:
Send the two specimens.
In the container were sodium thiosulfate is used as preservative, add 0.10 mL of a 10 % (m / m) sodium thiosulfate solution for every 125 mL of the sample.
6028
BACTERIOLOGICAL ANALYSIS (RD 140/2003) , DRINKING WATER
Method:
Look method for each procedure.
Mounting:
Delivery period:7
Sample:
1000 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Tests:
6500 - COLIFORM BACTERIA, DRINKING WATER
6514 - COLONY COUNT AT 22ºC, DRINKING WATER
6531 - E. COLI, DRINKING WATER
6555 - CLOSTRIDIUM PERFRINGENS (INCLUDING SPORES), DRINKING WATER
6556 - ENTEROCOCCI, DRINKING WATER
6029
BASIC PUBLIC USE ANALYSIS, SWIMMING POOL WATER
Method:
Look method for each procedure.
Mounting:
Delivery period:9
Sample:
200 mL Water (Recipient, plastic) (pH<2 Sulfuric Acid)
1000 mL Water (Recipient, sterile) ( Sodium Thiosulfate )
Sample extraction:
Send all the specimens.
In the container were sodium thiosulfate is used as preservative, add 0.10 mL of a 10 % (m / m) sodium thiosulfate solution for every 125 mL of the sample.
6097
BICARBONATE, WATER
Method:
Acid-base Titrations.
Mounting:
Delivery period:5
Sample:
200 mL Water (Recipient, plastic)
Parametric V.:
Not established.
Review:
09/05/2008
6100
BOD (BIOLOGICAL OXYGEN DEMAND), WATER
Method:
Iodometry
Mounting:
Delivery period:11
Sample:
200 mL Water (Recipient, glass)
Transport:
Protect from light.
Sample extraction:
Recipients should be filled completely (leaving no residual air volume).
Parametric V.:
Not established.
Review:
09/05/2008
6120
BROMIDE, WATER
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:10
Sample:
100 mL Water (Recipient, plastic)
Transport:
Protect from light.
Parametric V.:
Not established.
Review:
14/01/2004
6230
BORON, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic)
RD 140/2003:
< 1.00 mg/L
6304
BROMATE, DRINKING WATER
Method:
Ionic interchange Column chromatography (spectrometry detection).
Mounting:
Delivery period:10
Sample:
100 mL Water (Recipient, plastic)
Transport:
Protect from light.
RD 140/2003:
< 10.00 ug/L
6692
BOD (BIOLOGICAL OXYGEN DEMAND), WASTE WATER
Method:
Iodometry
Mounting:
Delivery period:11
Sample:
1000 mL Water (Recipient, plastic)
Transport:
Protect from light.
Sample extraction:
Recipients should be filled completely (leaving no residual air volume).
DC 130/2003:
< 750.00 mg/L
RD 849/1986:
Type II spill.: 40.01 - 60.00 mg/L
Type I spill.:
60.01 - 300.00 mg/L
Type III spill.:
<= to 40.00 mg/L
Review:
30/05/2011
6711
BORON, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic)
DC 130/2003:
< 3.00 mg/L
RD 849/1986:
Type II spill.: 2.01 - 5.00 mg/L
Type I spill.:
5.01 - 10.00 mg/L
Type III spill.:
<= to 2.00 mg/L
6740
BORON, DIALYSATE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic)
Parametric V.:
Not established.
6741
BORON, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic)
Parametric V.:
Not established.
6742
BORON, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic)
Parametric V.:
Not established.
6783
BICARBONATE, DRINKING WATER
Method:
Acid-base Titrations.
Mounting:
Delivery period:5
Sample:
200 mL Water (Recipient, plastic)
Parametric V.:
Not established.
Review:
14/06/2009
6819
BERYLLIUM, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6821
BERYLLIUM, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6823
BERYLLIUM, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
6825
BERYLLIUM, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
< 0.0004 mg/L
6826
BERYLLIUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)
Parametric V.:
Not established.
7043
BACTERIA´S IDENTIFICATION
Method:
Biochemical-Immunologic reaction.
Mounting:
Delivery period:7
Sample:
1 Sample/s Colonies (pure culture) (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Reported for each case
8008
BARTONELLA QUINTANA ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/64 Titulo
Positive:
>= to 1/64 Titulo
R.Values:
Parallel tests are recommended. The serum of the convalescent phase should be received at an interval of 30 days with respect to the acute phase.
Review:
11/03/2009
8009
BARTONELLA QUINTANA ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:5
Sample:
0.5 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
Review:
11/03/2009
8178
BORDETELLA PERTUSSIS ANTIBODIES, IgA, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:4
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/20 Titulo
Negative:
< 1/20 Titulo
Review:
22/12/2008
8253
BETA-GLUCOCEREBROSIDASE, LEUKOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:31
Sample:
10 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
Beta-Hexosaminidasa:
Reported for each case
Beta-Glucocerebrosidasa:
Reported for each case
Review:
07/02/2006
8269
BIOTINIDASE, PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:20
Sample:
1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
7.80 - 13.50 nmol/min/ml
8315
BASIC STUDY OF HEMÓLISIS, BLOOD
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:16
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
10 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
It´s necessary to contact previously with the laboratory for study programmation..
Sample extraction:
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.
Reference V.:
25.80 - 42.70 UI/g Hb
Índice PK/HK:
7.2 - 15.6 Índice
< 3.5 %
Glucosa-6-Fosfato Deshidrogenasa:
5.7 - 9.9 UI/g Hb
5.0 - 5.6 g/L
6-Fosfoglucanato Deshidrogenasa:
6.2 - 9.9 UI/g Hb
4.0 - 4.6 g/L
> 1800 seg
Piruvato Quinasa (PK):
8.4 - 15.2 UI/g Hb
< 2.0 %
Fosfohexosaisomerasa:
46.00 - 66.00 UI/g Hb
Hexoquinasa (HK):
0.60 - 1.26 UI/g Hb
Review:
23/01/2013
8316
BIOLOGICAL INVESTIGATION FAMILIAR PATERNITY (JUDICIAL VALUE), FROTIS
Method:
Polymerase chain reaction.
Mounting:
Delivery period:15
Sample:
2 Smear Buccal smear. (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
8317
BIOAVAILABLE TESTOSTERONE, SERUM
Method:
Calculation
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
4.57 - 14.94 nmol/L * 28.8184 = ng/dL
:

Adults Females 0.45 - 3.74 nmol/L * 28.8184 = ng/dL
Males 5.72 - 28.14 nmol/L * 28.8184 = ng/dL
Prepuberal Females 0.03 - 0.69 nmol/L * 28.8184 = ng/dL
Males 0.03 - 6.14 nmol/L * 28.8184 = ng/dL
Puberal Males 0.07 - 27.76 nmol/L * 28.8184 = ng/dL
Review:
27/03/2012
8325
BIOLOGICAL RESEARCH OF MOTHERHOOD (JUDICIAL VALUE), SMEAR
Method:
PCR-Fragment analysis.
Mounting:
Delivery period:16
Sample:
1 Smear Buccal smear. (12-20 ºC - Ambient Temp.)
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Reported for each case
Review:
27/03/2012
8327
BUPROPION/ HYDROXYPROPION, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:10
Sample:
2 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
Bupropion:

Peak level after adm. 150 mg/day (Bupropion) 32.00 - 100.00 ug/L
Peak level after adm. 300 mg/day (Bupropion) < 160.00 ug/L
Hidroxibupropion:

Peak level after adm. 150 mg/day (Hydroxybupropion) 230.00 - 580.00 ug/L
Peak level after adm. 300 mg/day 480.00 - 2240.00 ug/L
8462
BIOLOGICAL RESEARCH GENETIC IDENTITY
Method:
PCR-Fragment analysis.
Mounting:
Delivery period:10
Sample:
1 mL Buccal smear. (2-8 ºC - Refrigerate)
3 mL Total blood EDTA Na (2-8 ºC - Refrigerate)
Sample extraction:
Request the sample taking protocol to the laboratory.
Reference V.:
Reported for each case
Review:
08/07/2014
8472
BERYLLIUM, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:20
Sample:
3 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
< 0.33 mmol/L * 9.1 = ug/L
8500
BIOLOGICAL PATERNITY INVESTIGATION (LEGALLY VALID), BLOOD
Method:
Polymerase chain reaction.
Mounting:
Delivery period:16
Sample:
1 Sample/s Buccal smear. (2-8 ºC - Refrigerate)
3 mL Secretion Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Request the sample taking protocol to the laboratory.
Reference V.:
Inf.paternidad judicial:
Reported for each case
8501
BIOLOGICAL PATERNITY INVESTIGATION (NOT LEGALLY VALID), BLOOD
Method:
PCR-Capillary electrophoresis
Mounting:
Delivery period:16
Sample:
1 Sample/s Buccal smear. (2-8 ºC - Refrigerate)
Alt. 5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Request the sample taking protocol to the laboratory.
Reference V.:
Inf.paternidad no judici.:
Reported for each case
8518
BIOLOGICAL INVESTIGATION OF THE BROTHERHOOD (JUDICIAL VALUE)
Method:
Polymerase chain reaction.
Mounting:
Delivery period:15
Sample:
1 Sample/s Bucal smear (2-8 ºC - Refrigerate)
Sample extraction:
Request the sample taking protocol to the laboratory.
8731
BABESIA HUMANA ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:17
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/8
Negative:
< 1/8
Review:
17/06/2009
8733
BRANCHED FATTY ACIDS, SERUM
Method:
Gas Chromatography.
Mounting:
Delivery period:16
Sample:
1 mL Serum (-8 ºC - Freeze)
Reference V.:
ACIDO FITANICO:
< 2.00 ug/mL
< 1.00 ug/mL
Review:
06/02/2013
8798
B Cells CD38+/19+, BLOOD
Method:
Flux cytometry.
Mounting:
Delivery period:6
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Not available
8941
BORDETELLA DNA, BIOLOGICAL FLUID
Method:
Real Time PCR.
Mounting:
Delivery period:5
Sample:
1 mL Nasopharyngeal aspiration (2-8 ºC - Refrigerate)
Alt. 1 mL Secretion (2-8 ºC - Refrigerate)
Reference V.:
Is not detected
Review:
03/12/2013
10034
BUPRENORPHINE, URINE
Method:
Qualitative Immunochromatographie.
Mounting:
Delivery period:4
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
10150
BORRELIA BURGDORFERI ANTIBODIES, IgM, CSF
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:5
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Interpretation:
Indeterminate: 0.90 - 1.09 UA/mL
Positive:
> 1.09 UA/mL
Negative:
< 0.90 UA/mL
10200
BCR-ABL GENE p190 t(9;22) QUALITATIVE, BLOOD
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
Reported for each case
Review:
27/06/2014
10229
BRUGADA SYNDROME ( SCN5A GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
11/11/2011
10241
BENIGN FAMILIAL CHOREA (NKX2-1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
29/12/2011
10259
BETA-GLUCURONIDASE, SERUM
Method:
Fluorimetry
Mounting:
Delivery period:30
Sample:
7 mL Serum (-8 ºC - Freeze)
Request form:
Clinical information required.
Age is required.
Reference V.:
Reported for each case
10350
BICARBONATE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:6
Sample:
20 mL Urine (-8 ºC - Freeze)
Sample extraction:
Cap tube immediately to avoid contact with air.
Reference V.:
20.00 - 50.00 mmol/L * 1 = mEq/L
10618
BLACKFAN-DIAMOND ANEMIA (RPL11 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10619
BLACKFAN-DIAMOND ANEMIA (RPL35A GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10620
BLACKFAN-DIAMOND ANEMIA (RPL5 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10621
BLACKFAN-DIAMOND ANEMIA (RPL5 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10622
BLACKFAN-DIAMOND ANEMIA (RPS17 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10624
BLACKFAN-DIAMOND ANEMIA (RPS19 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10625
BLACKFAN-DIAMOND ANEMIA (RPS24 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10648
BARTTER SYNDROME TYPE 3 (CLCNKB GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:45
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10649
BARTTER SYNDROME TYPE 3 (CLCNKB GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10650
BARTTER SYNDROME TYPE 2 (KCNJ1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10651
BARTTER SYNDROME TYPE 4A (BSND GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10652
BECKWITH-WIEDEMANN SYNDROME (CDKN1C GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10653
BECKWITH-WIEDEMANN SYNDROME (LIT1 and H19 GENES: MS-MLPA), BLOOD
Method:
Metilation specífic MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10654
BIRT-HOGG-DUBÉ SYNDROME (FLCN GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10655
BIRT-HOGG-DUBÉ SYNDROME (FLCN GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10656
BRUGADA SYNDROME (SCN5A GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10925
BREAST/OVARIAN HEREDITARY CANCER (BRCA1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:30
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
11/02/2014
10926
BREAST/OVARIAN HEREDITARY CANCER (BRCA1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:20
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/04/2014
10927
BREAST/OVARIAN HEREDITARY CANCER (BRCA2 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:30
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
11/02/2014
10928
BREAST/OVARIAN HEREDITARY CANCER (BRCA2 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:20
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
17/04/2014
10969
BLACKFAN-DIAMOND ANEMIA (GENE RPL5), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
Reference V.:
Reported for each case
10975
BECKWITH-WIEDEMANN SD. (LIT1, H19 GENES: MS-MLPA), AMNIOTIC FLUID
Method:
Metilation specífic MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11001
BIOTINIDASE DEFICIENCY (BTD GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11032
BIRT-HOGG-DUBÉ SYNDROME (FLCN GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11122
BARTTER SYÍNDROME TYPE 4B (CLCNKA GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11586
BETA2-GLICOPROTEINA I ANTIBODIES IgA, SERUM
11603
BENZODIAZEPINES (SCREENING), SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Discriminant V.:
2.00
Reference V.:
Negative
11726
BRUCELLA ANTIBODIES IgM, CSF
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
11727
BRUCELLA IgM ANTIBODIES, LCR
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:6
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
11752
BANDS NOR (CONFIRMATION), BLOOD
Method:
Chromosomal analysis of the in cellular culture.
Mounting:
Delivery period:11
Sample:
3 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Alt. 3 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Do not use EDTA as an anticoagulant.
Reference V.:
Reported for each case
Review:
05/05/2015
11935
BETA2-MICROGLOBULIN, CSF
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
500 uL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
51.58 - 200.40 nmol/L
Review:
01/05/2014
11936
BETA-HYDROXYBUTYRATE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:11
Sample:
20 mL Urine (2-8 ºC - Refrigerate)
11948
BRUCELLA ANTIBODIES, SUERO
Method:
Immunocaptura-Precipitation.
Mounting:
Delivery period:26
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: > 1/320 Titulo
Negative:
<= to 1/320 Titulo
11949
BP-230 ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
14229
BRUCELLA SPP DNA, CSF
Method:
Nested-PCR.
Mounting:
Delivery period:7
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
06/08/2014
14406
BILE ACIDS, SERUM Baseline
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Baseline serum (2-8 ºC - Refrigerate)
Reference V.:
< 10.00 umol/L * 0.408497 = ug/mL
14407
BILE ACIDS, SERUM Postprandial
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum Postprandial (2-8 ºC - Refrigerate)
Reference V.:

At 2h (post-prandial) < 20.00 umol/L * 0.408497 = ug/mL
R.Values:
We interprete a normal result , when we obtain an increase three times less than the basal value.
Review:
23/11/2014
14425
BETA-GALACTOSIDASE, LEUCOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:32
Sample:
10 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
86.00 - 419.00 nmol/h/mg Prot.
14430
BCR-ABL GENE p190 t(9;22) QUALITATIVE, BONE MARROW
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
Reported for each case
Review:
29/11/2014
14431
BCR-ABL GENE p210 t(9;22) QUALITATIVE, BONE MARROW
Method:
Real Time RT-PCR.
Mounting:
Delivery period:11
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
Reported for each case
Review:
29/11/2014
14432
BCR-ABL GENE p210 t(9;22) QUANTIFICATION, BONE MARROW
Method:
Real Time PCR.
Mounting:
Delivery period:6
Sample:
10 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
< 0.01 Ratio Copias
14433
BCR-ABL GENE p190 t(9;22) QUANTIFICATION, BONE MARROW
Method:
Real Time RT-PCR.
Mounting:
Delivery period:6
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
To ensure specimen stability, we recommend not to send those specimens on Friday.
Reference V.:
< 0.01
Review:
29/11/2014
14652
BETA TRACE PROTEIN, BODY FLUID
Method:
Immunonephelometry.
Mounting:
Delivery period:8
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
1 mL Biologic fluid (2-8 ºC - Refrigerate)
1 mL Nasal secretion (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:

CSF 15.00 - 25.00 mg/L
Serum < 1.00 mg/L
Nasal, otic fluid < 1.00 mg/L
CSF Fistula > 1.11 mg/L
Review:
01/03/2015
14712
BETA-HYDROXYBUTYRATE, SERUM Baseline
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Baseline serum (2-8 ºC - Refrigerate)
Reference V.:
Both > 15 Years < 0.43 mmol/L
Both 0 15 Years 0.02 - 0.29 mmol/L
Review:
26/05/2015
14713
BETA-HYDROXYBUTYRATE, SERUM Post-prandial
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum Postprandial (2-8 ºC - Refrigerate)
Reference V.:
Not available
14848
BARDET-BIEDL SYNDROME TYPE 10 (BBS10 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14849
BARDET-BIEDL SYNDROME TYPE 10 (BBS10 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14996
BRAF ONCOGEN (V600E MUTATION), BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:25
Request form:
Clinical information required.
Reference V.:
Reported for each case
15093
BIETTI CORNEORETINAL DYSTROPHY (CYP4V2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15307
BRUGADA SYNDROME (SCN5A GENE), CHORIONIC VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.02 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15357
BRUCELLA ANTIBODIES (SEROAGGLUTINATIONS), SERUM
Method:
Agglutination.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Positive: >= to 1/80 Título
Negative:
< 1/80 Título
15446
BREAST/OVARIAN HEREDITARY CANCER (BRCA1 and BRCA2 GENES: NGS), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:60
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15550
BRANQUIO-OTO-RENAL SYNDROME (EYA1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15551
BASAL CELL NEVUS SYNDROME (PTCH1 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15552
BASAL CELL NEVUS SYNDROME (PTCH1 GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15650
BETA2-GLYCOPROTEIN I ANTIBODIES, IgM, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Low positive: 20.00 - 39.99 U/mL
Moderate positive:
40.00 - 79.99 U/mL
High positive:
>= to 80.00 U/mL
Negative:
< 20.00 U/mL
15653
BETA2-GLYCOPROTEIN I ANTIBODIES, IgG, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Low positive: 20.00 - 39.99 U/mL
Moderate positive:
40.00 - 79.99 U/mL
High positive:
>= to 80.00 U/mL
Negative:
< 20.00 U/mL
15686
BREAST AND OVARIAN CANCER (BRCA1 and BRCA2 GENES: NGS), BIOPSY
Method:
Next Generation Sequencing (NGS).
Mounting:
Delivery period:70
Request form:
Clinical information required.
Reference V.:
Reported for each case
6735
BARIUM, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:10
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
Review:
30/05/2009
6712
BARIUM, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 10.00 mg/L
RD 849/1986:
< 20.00 mg/L
Review:
27/05/2009
6729
BARIUM, SWIMMING POOL WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
Review:
27/05/2009
6229
BARIUM, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
Review:
27/05/2009
8577
BARIUM, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
5 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
< 2116.80 nmol/L * 0.137 = ug/L
Review:
12/12/2008
1280
BARIUM, URINE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
5 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
Use metal-free container.
Reference V.:
< 145.64 nmol/L * 0.137327 = ug/L
Review:
02/04/2008
1286
BISMUTH, SERUM
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
< 47.85 nmol/L * 0.208986 = ug/L
Review:
02/04/2008
14426
BISMUTH, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:12
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
< 23.93 nmol/L * 0.208986 = ug/L
11748
BORON, BLOOD
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
7.5 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
Reference V.:
< 4.07 umol/L * 10.81 = ug/L
Review:
23/01/2014
7896
BLOOD QUANTIFICATION, FECAL
Method:
Turbidimetry.
Mounting:
Delivery period:2
Sample:
2 g Faeces (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Collect in specific recipient with airtight closure and preparation.
Reference V.:
Positive: > 17.00 ng Hb/mg heces * 5.88235 = ng/mL heces
Negative:
<= to 17.00 ng Hb/mg heces * 5.88235 = ng/mL heces
15761
BROMAZEPAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
80.00 - 200.00 µg/L * 0.003163 = µmol/L
8846
BCR-ABL GENE p210 t(9;22) QUANTIFICATION, BONE MARROW
Method:
Real Time RT-PCR.
Mounting:
Delivery period:6
Sample:
3 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.